Clinical Trial Update: Evaluating the Efficacy and Safety of Teprotumumab N01 in Patients With Thyroid Eye Disease. [NA]

View source ↗

Summary

A clinical trial update indicating that Teprotumumab N01 is being studied to evaluate its efficacy and safety in patients with Thyroid Eye Disease, currently re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Thyroid Eye Disease

Drugs mentioned

• Teprotumumab N01 (teprotumumab)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Thyroid Eye Disease | NA | Status: RECRUITING